Skip to main content

Table 1 Characteristics of the patients

From: Feasibility of modified radical mastectomy with nipple-areola preservation combined with stage I prosthesis implantation using air cavity-free suspension hook in patients with breast cancer

Characteristics

SMALND

(n=30)

Control

(n=57)

P

Age, years, mean±SD

43.7±7.7

45.2±8.4

0.390

BMI, kg/m2, mean±SD

22.2±2.0

21.8±2.7

0.477

Stage, n (%)

  

0.555

 I

17 (56.7)

36 (63.2)

 

 II

13 (43.3)

21 (36.8)

 

Height, m, mean±SD

1.63±0.04

1.63±0.04

0.606

Weight, kg, mean±SD

58.97±6.30

58.02±6.01

0.500

Subtypes, n (%)

 Luminal A

4 (13.3)

8 (14.0)

0.928

 Luminal B (HER−)

6 (20.0)

14 (24.6%)

0.631

 Luminal B (HER+)

6 (20.0)

16 (28.1)

0.410

 HER2+

9 (30.0)

8 (14.0%)

0.074

 Triple negative

5 (16.7)

11 (19.3)

0.873

ER-positive, n (%)

16 (53.3)

38 (66.7)

0.223

PR-positive, n (%)

16 (53.3)

38 (66.7)

0.223

HER2-positive, n (%)

15 (50.0)

24 (42.1)

0.482

  1. SD Standard deviation, BMI Body mass index, SMALND Mastoscopic modified radical mastectomy with nipple-areola preservation combined with stage I prosthesis implantation under air cavity-free suspension hook, ER Estrogen receptors, PR Progesterone receptor